Diagnostic testing methods for Clostridium difficile infection: A statewide survey of Ohio acute care hospitals

We surveyed Ohio acute care hospitals on laboratory testing used for diagnosis of Clostridium difficile infection (CDI). Of 146 hospitals surveyed, 109 (84%) used nucleic acid amplification tests (NAATs) as stand-alone diagnostic assays. Only 53 (42.4%) hospitals using NAATs had a mechanism in place...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of infection control Vol. 45; no. 3; pp. 306 - 307
Main Authors Wong, Ken Koon, MD, Choi, Byungwoo, MD, Fraser, Thomas G., MD, Donskey, Curtis J., MD, Deshpande, Abhishek, MD, PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2017
Mosby-Year Book, Inc
Subjects
Bioassays
Clostridium difficile
Clostridium difficile - isolation & purification
Clostridium Infections - diagnosis
Diagnostic tests
Diagnostic Tests, Routine - methods
Gram-positive bacteria
Hospitals
Humans
Infection Control
Infectious Disease
Intensive care
Medical tests
Molecular testing
NAAT
Nosocomial infections
Ohio
Surveys and Questionnaires
United States > US
Ohio
Molecular testing
NAAT
Diagnostic tests
Clostridium difficile
Online AccessGet full text

Cover

More Information
Summary:We surveyed Ohio acute care hospitals on laboratory testing used for diagnosis of Clostridium difficile infection (CDI). Of 146 hospitals surveyed, 109 (84%) used nucleic acid amplification tests (NAATs) as stand-alone diagnostic assays. Only 53 (42.4%) hospitals using NAATs had a mechanism in place to prevent repeat CDI testing.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0196-6553
1527-3296
DOI:10.1016/j.ajic.2016.09.007